URL details: www.opdivogastroeso.com/
URL title:
Adjuvant and Metastatic Gastroesophageal Cancers | OPDIVO® (nivolumab) and OPDIVO + FOLFOX or CapeOX
URL description:
OPDIVO® (nivolumab), alone or in combination, is approved in UGI cancers in both the adjuvant and 1L metastatic setting. Please see Indications and Important Safety Information.
URL last crawled:
2022-08-31
URL speed:
0.490 MB/s,
downloaded in 0.200 seconds
1 external links to this url
Only links from external domains are shown on this page.